ANDA 76211, held by Teva. Benazepril Hydrochloride.
As of Nov 16, 2026, ANDA 76211 (Benazepril Hydrochloride), held by Teva, was first approved by FDA on Feb 11, 2004, with 14 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 11, 2004 | Original application | Approved |
| Benazepril Hydrochloride5MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride10MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride20MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride40MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Nov 28, 2017 | Supplement 22Labeling · Standard review | Approved | None posted |
| Oct 19, 2015 | Supplement 21Labeling · Standard review | Approved | None posted |
| Apr 22, 2015 | Supplement 20Labeling · Standard review | Approved | None posted |
| Apr 22, 2015 | Supplement 19Labeling · Standard review | Approved | None posted |
| Apr 22, 2015 | Supplement 18Labeling · Standard review | Approved | None posted |
| Nov 8, 2012 | Supplement 16Labeling · Standard review | Approved | None posted |
| Nov 8, 2012 | Supplement 15Labeling | Approved | None posted |
| Jul 22, 2011 | Supplement 14Labeling | Approved | None posted |
| Jan 28, 2010 | Supplement 12Labeling | Approved | None posted |
| May 27, 2009 | Supplement 8Labeling | Approved | None posted |
| Mar 20, 2009 | Supplement 6Labeling | Approved | None posted |
| Nov 19, 2008 | Supplement 5Labeling | Approved | None posted |
| Apr 29, 2008 | Supplement 4Labeling | Approved | None posted |
| Dec 19, 2006 | Supplement 3Labeling | Approved | None posted |
| Feb 11, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters